ロード中...
Melanoma in Situ Treated with Topical Imiquimod for Management of Persistently Positive Margins: A Review of Treatment Methods
BACKGROUND: Imiquimod is a topical cream approved by the US Food and Drug Administration for treatment of superficial basal cell carcinoma, actinic keratosis, and genital-perianal warts. Its successful use in patients with persistently positive margins of melanoma in situ (MIS) after surgical excisi...
保存先:
| 出版年: | Ochsner J |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
the Academic Division of Ochsner Clinic Foundation
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4679308/ https://ncbi.nlm.nih.gov/pubmed/26730231 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|